Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2020-06-05
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Neurophysiological Correlates of the Link Between Perception and Action
NCT02851121
Vestibular and Multisensory Influence on Bodily and Spatial Representations
NCT02072460
Subjective Perception of Motor Control During Psychogenic Disorders
NCT02843932
Verticality Perception - Multisensory Contribution
NCT02212704
Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy Volunteers
NCT01900457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy volunteers
EEG and occulometry
Each participants will spend two sessions of EEG and occulometry during a visual cognitive task where she/her will be presented with multi-stable visual stimuli to gaze at for one or two minutes. Depending on the experimental conditions, the participant will provide or not her/his perceptual state (i.e. which stimulus has been perceived ).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EEG and occulometry
Each participants will spend two sessions of EEG and occulometry during a visual cognitive task where she/her will be presented with multi-stable visual stimuli to gaze at for one or two minutes. Depending on the experimental conditions, the participant will provide or not her/his perceptual state (i.e. which stimulus has been perceived ).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medical examination carried out before the participation in the research
* Age between 18 and 55 years
* Minimum level of studies
* Obligation to join the social security system
* normal or corrected vision normal
Exclusion Criteria
* Major vision disorder
* Past or current neurological or neuropsychiatric pathologies
* History of cranial trauma with loss of consciousness.
* Medication treatments likely to modulate brain activity: benzodiazepine, antidepressants, neuroleptics, lithium, etc.
* Diabetes, cardiac pathology, immunodeficiency.
* Medication treatments likely to modulate the activity of the cardiovascular system.
* History of abuse or recent ingestion of alcohol, hard drugs or doping products.
* Consumption of more than 15 cigarettes per day
* Subject deprived of liberty by a judicial or administrative decision (L1121-6 CSP)
* Major subject subject to a legal protection measure or unable to express their consent (L1121-8 CSP)
* Pregnant, parturient and nursing mothers (L1121-5)
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GIPSA-LAB
OTHER
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Grenoble-Alpes
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anne GUERIN
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
38RC18.059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.